Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 4/20 | 0.50 |
| ▸ | CA1 | P00915 | 4/20 | 0.50 |
| ▸ | CA2 | P00918 | 4/20 | 0.50 |
| ▸ | CA7 | P43166 | 4/20 | 0.50 |
| ▸ | CA9 | Q16790 | 4/20 | 0.50 |
| ▸ | CA14 | Q9ULX7 | 4/20 | 0.50 |
| ▸ | TPMT | P51580 | 3/20 | 0.48 |
| ▸ | CA4 | P22748 | 3/20 | 0.48 |
| ▸ | CA6 | P23280 | 3/20 | 0.48 |
| ▸ | TP53 | P04637 | 2/20 | 0.48 |
| ▸ | CA3 | P07451 | 2/20 | 0.48 |
| ▸ | CA5A | P35218 | 2/20 | 0.48 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.48 |
| ▸ | MAPT | P10636 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | SELL | P14151 | 1/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.48 |
| ▸ | SELP | P16109 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL433003 | 0.94 | CA12 (0.50) | CA12CA1CA2CA7CA9 | |
| SCHEMBL28454802 | 0.92 | CA12 (0.48) | CA12CA1CA2CA7CA9 | |
| SCHEMBL11772782 | 0.83 | TPMT (0.70) | CA12CA1CA2CA7CA9 | |
| SCHEMBL6085945 | 0.83 | KDM4E (0.47) | CA12CA1CA2CA7CA9 | |
| SCHEMBL11820909 | 0.83 | HCAR1 (0.59) | CA12CA1CA2CA7CA9 | |
| SCHEMBL7428766 | 0.83 | CA12 (0.41) | CA12CA1CA2CA7CA9 | |
| SCHEMBL12977996 | 0.83 | TPMT (0.44) | CA12CA1CA2CA7CA9 | |
| SCHEMBL11819100 | 0.83 | POLB (0.47) | CA12CA1CA2CA7CA9 | |
| SCHEMBL23699475 | 0.78 | KDM4E (0.50) | CA12CA1CA2CA7CA9 | |
| SCHEMBL19259661 | 0.78 | DHODH (0.59) | TSHRDAONAPRT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-121559814-B | Ultraviolet curing nano-imprint photoresist with semi-interpenetrating network structure and preparation method thereof | 中国科学技术大学 | 2026-05-12 | — | — | CN | claimed |
| EP-3859804-B1 | SEMICONDUCTOR DEVICE HAVING QUANTUM DOTS | CANON KK (JP) | 2024-08-07 | — | — | EP | claimed |
| CN-121559814-B | Ultraviolet curing nano-imprint photoresist with semi-interpenetrating network structure and preparation method thereof | 中国科学技术大学 | 2026-05-12 | — | — | CN | disclosed |
| US-12245446-B2 | Semiconductor device having quantum dots, display device, imaging system, and moving body | CANON KABUSHIKI KAISHA (JP) | 2025-03-04 | — | — | US | disclosed |
| EP-3859804-B1 | SEMICONDUCTOR DEVICE HAVING QUANTUM DOTS | CANON KK (JP) | 2024-08-07 | — | — | EP | disclosed |
| CN-116920127-A | Stimulus-responsive self-assembled magnetic resonance contrast agent drug-loading system and preparation method thereof | 浙江省肿瘤医院 | 2023-10-24 | — | — | CN | disclosed |
| CN-116125066-A | Stimulus response type magnetic SERS composite nano probe and preparation method and application thereof | 浙江省肿瘤医院 | 2023-05-16 | — | — | CN | disclosed |
| US-11346785-B2 | Detection of pH | UNITED KINGDOM RESEARCH AND INNOVATION (GB) | 2022-05-31 | — | — | US | disclosed |
| US-20220153783-A1 | MITOCHONDRIA-TARGETING COMPOUND AND COMPOSITION COMPRISING SAME FOR TREATING OR PREVENTING AGING-RELATED DISEASES | FUSION BIOTECHNOLOGY CO., LTD. (KR) | 2022-05-19 | — | — | US | disclosed |
| EP-3925961-A1 | MITOCHONDRIA-TARGETING COMPOUND AND COMPOSITION COMPRISING SAME FOR TREATING OR PREVENTING AGING-RELATED DISEASES | Fusion Biotechnology Co., Ltd. (KR) | 2021-12-22 | — | — | EP | disclosed |
| CN-113285024-A | Semiconductor device having quantum dots, display device, imaging system, and moving object | 佳能株式会社 | 2021-08-20 | — | — | CN | disclosed |
| US-7850949-B2 | Purification of synthetic oligomers | MICHIGAN TECHNOLOGICAL UNIVERSITY (US) | 2010-12-14 | — | — | US | disclosed |
| US-20080081902-A1 | PURIFICATION OF SYNTHETIC OLIGOMERS | MICHIGAN TECHNOLOGICAL UNIVERSITY | 2008-04-03 | — | — | US | disclosed |
| US-7205428-B2 | Thioether derivatives, their method for production and use | NATIONAL INSTITUTE OF INFORMATION AND COMMUNICATIONS TECHNOLOGY, INCORPORATED ADMINISTRATIVE AGENCY (JP) | 2007-04-17 | — | — | US | disclosed |
| US-7205428-B2 | Thioether derivatives, their method for production and use | NATIONAL INSTITUTE OF INFORMATION AND COMMUNICATIONS TECHNOLOGY, INCORPORATED ADMINISTRATIVE AGENCY (JP) | 2007-04-17 | — | — | US | disclosed |
| EP-1219667-B1 | Novel thioether derivatives, their method for production and use | COMM RES LAB INDEPENDENT ADMIN (JP) | 2004-08-04 | — | — | EP | disclosed |
| US-6630578-B2 | Which respond immediately by emission of light when stimulated with light or electric energy, and are useful as switching material of memory | COMMUNICATIONS RESEARCH LABORATORY, INDEPENDENT ADMINISTRATIVE INSTITUTION (JP) | 2003-10-07 | — | — | US | disclosed |
| US-20030171507-A1 | Novel thioether derivatives, their method for production and use | NATIONAL INSTITUTE OF INFORMATION AND COMMUNICATIONS TECHNOLOGY, INCORPORATED ADMINISTRATIVE AGENCY (JP) | 2003-09-11 | — | — | US | disclosed |
| EP-1219667-A2 | Novel thioether derivatives, their method for production and use | Communications Research Laboratory, Independent Administrative Institution (JP) | 2002-07-03 | — | — | EP | disclosed |
| US-20020072583-A1 | Novel thioether derivatives, their method for production and use | NATIONAL INSTITUTE OF INFORMATION AND COMMUNICATIONS TECHNOLOGY, INCORPORATED ADMINISTRATIVE AGENCY (JP) | 2002-06-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080081902-A1 | PURIFICATION OF SYNTHETIC OLIGOMERS | RNGTT, NOP2, CAPZA2 | CA12 1930/4885CA1 2015/4885CA2 1789/4885 |
| US-20220153783-A1 | MITOCHONDRIA-TARGETING COMPOUND AND COMPOSITION COMPRISING SAME FOR TREATING OR PREVENTING AGING-RELATED DISEASES | TFAM, HSPA9, AIFM1 | CA12 4746/4885CA1 4542/4885CA2 2758/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.